Insta
Mumbai Based Pharmaceutical Giant Cipla Partners With Govt Labs To Produce Effective Drugs For Covid-19
Swarajya Staff
Mar 21, 2020, 01:31 PM | Updated 01:31 PM IST
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
Mumbai based pharmaceutical giant Cipla has embarked on fast-tracked development of drugs to cure COVID-19 in partnership with Government laboratories, while repurposing its gamut of respiratory, asthma, antivirals and HIV drugs to defeat the spread of COVID-19 in India, reports Times of India.
It should also be noted that Cipla's drug Actemra which is used in treating rheumatoid arthritis was recently approved by China for usage in the treatment of patients with severe complications associated with COVID-19.
Known for many innovations in respiratory, HIV and flu therapy, Cipla's promoter Yusuf Hamied said, "We consider it a nationalistic duty to put up all our resources to benefit the country."
The company, which was one of the first ones to launch a generic cure to H1N1 influenza is now aiming to become the first domestic company to introduce drugs against COVID-19.
The company is presently looking into the production of raw materials with the help of Government laboratories for antiviral compounds like favipiravir, remidesivir and bolaxavir. It should be noted though that the final drugs will take about six months to be launched after the procurement of raw materials (active pharmaceutical ingredients) begins.
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
Introducing ElectionsHQ + 50 Ground Reports Project
The 2024 elections might seem easy to guess, but there are some important questions that shouldn't be missed.
Do freebies still sway voters? Do people prioritise infrastructure when voting? How will Punjab vote?
The answers to these questions provide great insights into where we, as a country, are headed in the years to come.
Swarajya is starting a project with an aim to do 50 solid ground stories and a smart commentary service on WhatsApp, a one-of-a-kind. We'd love your support during this election season.
Click below to contribute.